Unidade Local de Saúde de São João, EPE

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Amyloidosis1 trial
• Rheumatoid arthritis1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Ionis Pharmaceuticals, Inc.1 trial
• SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd1 trial

Running trials

• Enrolling by invitation

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· Phase 3· Ionis Pharmaceuticals, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis1 recruiting

Closed trials

• Completed

  Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

  NCT06565273· Phase 2· SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd· Source